Indonesia Inflation Lowest In 3 Months

Indonesia's inflation rate eased to the lowest in three months in November, data from the statistics bureau showed on Thursday.

The consumer price index, or CPI, rose 5.42 percent year-on-year in November after a 5.71 percent increase in October, the statistical bureau in Jakarta said. Economists had expected the annual inflation rate to rise to 5.55 percent.

The latest inflation was the lowest since August, when prices rose 4.69 percent.

Prices for food, beverages and tobacco grew 5.87 percent annually in November and those of housing, water, electricity and household fuels gained 3.24 percent.

Prices for furnishings, household equipment and routine household maintenance surged by 4.96 percent. Prices for health, and clothing and footwear advanced by 2.90 percent and 1.53 percent, respectively.

The core inflation was 3.30 percent yearly in November. Economists had forecast 3.4 percent.

On a month-on-month basis, consumer prices increased 0.09 percent in November. Economists had expected a growth of 0.16 percent.

Compared to the previous month, the core CPI rose 0.15 percent in November.

Bank Indonesia has forecast average inflation rate of 5.9 percent by the end of this year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT